Clonal hematopoiesis in prostate cancer inferred from somatic tumor profiling. A prospective phase 2/3 study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results